Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients.
Humans
Female
Neoadjuvant Therapy
/ methods
Iodine Radioisotopes
/ therapeutic use
Breast Neoplasms
/ drug therapy
Neoplasm Staging
Thyroid Neoplasms
Lymph Nodes
/ pathology
Sentinel Lymph Node
/ pathology
Sentinel Lymph Node Biopsy
/ methods
Lymph Node Excision
/ methods
Lymphadenopathy
/ pathology
Axilla
/ pathology
Journal
Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
12
08
2023
revised:
28
09
2023
accepted:
13
10
2023
medline:
5
12
2023
pubmed:
20
10
2023
entrez:
19
10
2023
Statut:
ppublish
Résumé
Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the axillary staging method during surgery remains controversial. There are at least three validated methods: SLNB, targeted axillary dissection (TAD) and marking axillary nodes with radioactive iodine seeds (MARI) procedure. Our house believe that the biopsied and clipped lymph node could predict response to systemic treatment.
Identifiants
pubmed: 37857128
pii: S0960-9776(23)00568-4
doi: 10.1016/j.breast.2023.103592
pmc: PMC10598034
pii:
doi:
Substances chimiques
Iodine Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103592Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.